Hypertrophic scar

Jan 27, 2020

Soliton Announces Positive Data from Extended Keloid and Hypertrophic Scar Trials

Jan 13, 2020

Soliton To Announce Keloid and Hypertrophic Scar Clinical 12-Week Trial Data at Maui Derm Meeting

Oct 08, 2019

Soliton to Announce Keloid and Hypertrophic Scar Clinical Trial Data on October 24, 2019

Oct 01, 2019

Soliton Completes Keloid POC Clinical Trial Treatments

Sep 19, 2019

Soliton Begins Treatments In Proof-Of-Concept Trial For Keloid Scars

Sep 17, 2019

Soliton Completes Trial Enrollment and Conducts Initial Site Training to Start Keloid Trial

Sep 10, 2019

Soliton Announces Site Selected for Clinical Trial to Treat Fibrotic Scars

Aug 29, 2019

Soliton to Initiate POC Clinical Trials to Treat Fibrotic Scars Using Acoustic Shockwaves; Estimated Market Size of $10 Billion by 2025

Dec 12, 2018

Lines of Defense: Understanding and Treating Scarred Skin

Dec 18, 2017

RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with RXI-109 for Dermal Scarring

Oct 06, 2017

Sirnaomics Publishes Results Showing Dual Targeting of TGF-b1 and COX-2 Reduces Human Skin Hypertrophic Scar through Activation of Fibroblast Apoptosis